全膝关节置换术中髌骨置换与未置换的阿片类药物消耗趋势
本研究回顾性分析了2018至2022年间982例初次全膝关节置换术,比较髌骨置换(535例)与未置换(447例)患者术后阿片类药物消耗。结果显示髌骨置换组术后30天平均吗啡毫克当量消耗更高(705 vs 551,P<0.001),处方数量更多(2.56 vs 2.09,P<0.001)。作者认为在髌骨关节炎有限的情况下,髌骨置换可能影响术后阿片类药物消耗。
要点
- 髌骨置换组术后30天平均吗啡毫克当量消耗为705,高于未置换组的551(P<0.001)。
- 髌骨置换组术后30天处方填充数量为2.56,多于未置换组的2.09(P<0.001)。
- 两组达到膝关节骨关节炎结局评分关节置换版最小临床重要差异的患者比例相当。
核心结论
- 髌骨置换患者术后30天阿片类药物消耗高于未置换患者。
- 作者认为,在髌骨关节炎有限的情况下,髌骨置换可能影响术后阿片类药物消耗,外科医生应有所认识。
研究设计与样本
- 回顾性研究,纳入2018至2022年间在单一高容量机构由实行选择性或普遍髌骨置换的关节置换外科医生完成的初次全膝关节置换术。
- 共纳入982膝,其中447膝未行髌骨置换,535膝行髌骨置换。
- 术前日出位X线片采用Iwano分类评估髌股关节炎严重程度;阿片类药物处方数据来自处方药监测计划并转换为吗啡毫克当量。
主要发现
- 未置换组男性比例为52.8%,置换组为33.1%(P<0.001);两组年龄无差异(67.2 vs 67.7,P=0.431)。
- 术后前30天,髌骨置换组平均吗啡毫克当量消耗为705,未置换组为551(P<0.001)。
- 术后前30天,髌骨置换组处方填充数量为2.56,未置换组为2.09(P<0.001)。
- 两组达到膝关节骨关节炎结局评分关节置换版最小临床重要差异的患者百分比相当。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patellar resurfacing in total knee arthroplasty (TKA) is a highly debated topic, with equivocal results. While past literature has investigated pain, functional outcomes, and the cost of resurfaced versus unresurfaced patellae, examining opioid consumption is critical in the wake of the opioid epidemic. We sought to compare postoperative opioid consumption in patients who did and did not undergo patellar resurfacing in primary TKA. METHODS: This was a retrospective review of primary TKAs between 2018 and 2022 performed at a single high-volume institution with arthroplasty surgeons who practiced either selective or universal patellar resurfacing. Preoperative sunrise radiographs were reviewed to assess the severity of patellofemoral arthritis using the Iwano classification. Opioid prescription data were obtained from the Prescription Drug Monitoring Program and converted to morphine milligram equivalents (MMEs). Primary outcomes included total MME consumption and prescriptions filled. Secondary outcomes included length of stay, readmission, and patient-reported outcome measures. Of the 982 knees included, 447 were unresurfaced and 535 were resurfaced. There was a greater proportion of men in the unresurfaced versus the resurfaced group (52.8 versus 33.1%; P < 0.001); however, there was no difference in age (67.2 versus 67.7; P = 0.431). RESULTS: For the first 30 days postoperatively, the resurfaced group had a greater average MME consumption than the unresurfaced group (705 versus 551 MME, respectively [P < 0.001]). The resurfaced group also filled more prescriptions during this period (2.56 versus 2.09 [P < 0.001]). The percentage of patients who met the minimal clinically important difference (MCID) for the Knee Osteoarthritis and Outcome Score for Joint Replacement was equivalent. CONCLUSIONS: Patients who had resurfaced patellae had a greater opioid consumption in the first 30 days postoperatively compared to those who had unresurfaced patellae. Surgeons should be cognizant that patellar resurfacing in the setting of limited patellar arthritis may influence postoperative opioid consumption.
引用
- Leipman JH, Sutton R, Hohmann AL, et al. Opioid Consumption Trends in Resurfaced versus Unresurfaced Patellae in Total Knee Arthroplasty. J Arthroplasty. 2026. PMID: 41506405. doi:10.1016/j.arth.2026.01.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。